These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16411967)

  • 1. Use of levetiracetam in treating epilepsy associated with other medical conditions.
    Di Bonaventura C; Mari F; Fattouch J; Egeo G; Vaudano AE; Manfredi M; Prencipe M; Giallonardo AT
    Acta Neurol Scand; 2006 Feb; 113(2):82-6. PubMed ID: 16411967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ; Somerville ER; Van Paesschen W; Ryvlin P; Schelstraete I
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
    Brodtkorb E; Klees TM; Nakken KO; Lossius R; Johannessen SI
    Epilepsy Behav; 2004 Apr; 5(2):231-5. PubMed ID: 15123025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
    Gidal BE; Baltès E; Otoul C; Perucca E
    Epilepsy Res; 2005; 64(1-2):1-11. PubMed ID: 15823510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience.
    Leppik I; De Rue K; Edrich P; Perucca E
    Epileptic Disord; 2006 Jun; 8(2):118-30. PubMed ID: 16793573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes.
    Di Bonaventura C; Fattouch J; Mari F; Egeo G; Vaudano AE; Prencipe M; Manfredi M; Giallonardo AT
    Epileptic Disord; 2005 Sep; 7(3):231-5. PubMed ID: 16162433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in the treatment of idiopathic generalized epilepsies.
    Grünewald R
    Epilepsia; 2005; 46 Suppl 9():154-60. PubMed ID: 16302890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disfluent speech in patients with partial epilepsy: beneficial effect of levetiracetam.
    Sechi G; Cocco GA; D'Onofrio M; Deriu MG; Rosati G
    Epilepsy Behav; 2006 Nov; 9(3):521-3. PubMed ID: 16971185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.